Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1100-88-5 Chemical Structure| 1100-88-5

Structure of 1100-88-5

Chemical Structure| 1100-88-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1100-88-5 ]

CAS No. :1100-88-5
Formula : C25H22ClP
M.W : 388.87
SMILES Code : C1([P+](C2=CC=CC=C2)(CC3=CC=CC=C3)C4=CC=CC=C4)=CC=CC=C1.[Cl-]
MDL No. :MFCD00011913
InChI Key :USFRYJRPHFMVBZ-UHFFFAOYSA-M
Pubchem ID :70671

Safety of [ 1100-88-5 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H300+H330-H311-H315-H319-H335-H411
Precautionary Statements:P260-P273-P280-P301+P310+P330-P304+P340+P310-P403+P233
Class:6.1
UN#:2811
Packing Group:

Computational Chemistry of [ 1100-88-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 27
Num. arom. heavy atoms 24
Fraction Csp3 0.04
Num. rotatable bonds 5
Num. H-bond acceptors 0.0
Num. H-bond donors 0.0
Molar Refractivity 121.35
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

13.59 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

-0.88
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

6.92
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.03
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

6.69
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

6.16
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

4.18

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-6.94
Solubility 0.0000448 mg/ml ; 0.000000115 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-7.02
Solubility 0.0000374 mg/ml ; 0.0000000961 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-10.42
Solubility 0.0000000146 mg/ml ; 0.0 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Insoluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-3.76 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

1.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

4.48

Application In Synthesis of [ 1100-88-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1100-88-5 ]

[ 1100-88-5 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 7089-68-1 ]
  • [ 1100-88-5 ]
  • [ 163231-36-5 ]
  • 2
  • [ 1100-88-5 ]
  • [ 193480-28-3 ]
  • [ 313950-43-5 ]
  • 3
  • [ 2142-06-5 ]
  • [ 1100-88-5 ]
  • (5E)-1-benzyl-5-benzylidenepyrrolidin-2-one [ No CAS ]
  • 4
  • [ 43192-34-3 ]
  • [ 1100-88-5 ]
  • C15H13BrO [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: To a solution of benzyl chloride (0.126 g, 1.00 mmol) in dry toluene (7 mL), was added triphenylphosphine (0.313 g, 1.20 mmol) at ambient temperature. The reaction mixture was allowed to reflux for 18 h under N2 atmosphere; during this time the Wittig salt precipitated out, it was filtered, washed and used for further reaction. To a solution of Wittig salt (0.08 g, 0.20 mmol) in CH2Cl2, was added NaOH solution (0.01 g, 0.25 mmol, 3 mL water) at ambient temperature. The solution turned orange red indicating the formation of Wittig ylide. To this solution was added benzaldehyde (0.018 g, 0.16 mmol) and the reaction mixture allowed to stir at ambient temperature for 3 h. The crude product formed was extracted with CH2Cl2, washed with brine and evaporated to dryness. After usual column chromatography (hexane: EtOAc; 9:1), the product obtained was a mixture of cis and trans-isomer, isolated in 87percent yield. The above mixture was dissolved in hexane containing catalytic amount of iodine and allowed to reflux for 1 h. The reaction mixture was cooled down to ambient temperature, washed with Na2S2O5 solution and the organic layer evaporated to give pure trans-isomer (1) in quantitative yield (89percent)
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1100-88-5 ]

Aryls

Chemical Structure| 1530-39-8

A494980 [1530-39-8]

(4-Chlorobenzyl)triphenylphosphonium chloride

Similarity: 0.85

Chemical Structure| 1530-39-8

A494980 [1530-39-8]

(4-Chlorobenzyl)triphenylphosphonium chloride

Similarity: 0.85